Cara Therapeutics (CARA) Stock Chart & Stock Price History → If you have $2,500 bucks… check this out (From DTI) (Ad) Free CARA Stock Alerts $0.69 +0.01 (+1.36%) (As of 09:43 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cara Therapeutics Stock Price Performance5 Day Performance+3.28%1 Month Performance-23.78%3 Month Performance+13.70%6 Month Performance-34.57%Year-To-Date Performance-6.65%1 Year Performance-83.49% Receive CARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. CARA Stock Chart for Monday, April, 29, 2024 CARA Chart by TradingView Cara Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.70$0.68-2.24%$0.73$0.68169,234 shs$37.41 million04/25/2024$0.67$0.70+4.23%$0.72$0.64318,977 shs$38.27 million04/24/2024$0.71$0.67-5.02%$0.72$0.66216,111 shs$36.71 million04/23/2024$0.73$0.71-3.19%$0.73$0.70181,919 shs$38.65 million04/22/2024$0.66$0.73+10.50%$0.74$0.65346,161 shs$39.92 million04/19/2024$0.69$0.66-4.20%$0.70$0.65350,693 shs$36.13 million Get the Latest News and Ratings for CARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.73$0.69-5.72%$0.74$0.68363,035 shs$37.72 million04/17/2024$0.71$0.73+3.23%$0.75$0.70184,641 shs$40.01 million04/16/2024$0.71$0.71-0.14%$0.72$0.63601,466 shs$38.75 million04/15/2024$0.76$0.71-7.08%$0.78$0.70439,580 shs$38.81 million04/12/2024$0.81$0.76-5.74%$0.83$0.76306,332 shs$41.77 million04/11/2024$0.81$0.81-0.17%$0.83$0.80214,479 shs$44.31 million04/10/2024$0.83$0.81-2.40%$0.83$0.80356,901 shs$44.38 million04/09/2024$0.83$0.83+0.79%$0.86$0.82272,045 shs$45.48 million04/08/2024$0.87$0.83-5.60%$0.88$0.74579,089 shs$45.12 million04/05/2024$0.83$0.87+5.90%$0.89$0.81453,165 shs$47.80 million04/04/2024$0.91$0.83-8.99%$0.95$0.81454,533 shs$45.14 million04/03/2024$0.92$0.91-1.32%$0.95$0.88318,550 shs$49.60 million04/02/2024$0.91$0.92+1.04%$0.93$0.89270,372 shs$50.26 million04/01/2024$0.91$0.91$0.94$0.86328,868 shs$49.74 million03/29/2024$0.91$0.91$0.96$0.85637,279 shs$49.74 million03/28/2024$0.87$0.91+4.72%$0.96$0.85637,269 shs$49.74 million03/27/2024$0.73$0.87+19.01%$0.88$0.75569,125 shs$47.50 million03/26/2024$0.82$0.73-10.94%$0.84$0.72704,133 shs$39.91 million03/25/2024$0.88$0.82-7.18%$0.92$0.81470,703 shs$44.81 million03/22/2024$0.89$0.88-0.93%$0.94$0.88204,796 shs$48.28 million03/21/2024$0.90$0.89-1.24%$0.94$0.88218,674 shs$48.74 million03/20/2024$0.89$0.90+1.44%$0.95$0.83504,687 shs$49.34 million03/19/2024$0.91$0.89-1.92%$0.95$0.82332,776 shs$48.65 million03/18/2024$0.88$0.91+3.34%$0.93$0.80375,839 shs$49.60 million03/15/2024$0.79$0.88+11.65%$0.89$0.76745,155 shs$47.99 million03/14/2024$0.87$0.79-9.62%$0.89$0.741.04 million shs$42.99 million03/13/2024$0.88$0.87-1.11%$0.92$0.85414,315 shs$47.57 million03/12/2024$0.95$0.88-7.36%$0.95$0.85681,108 shs$48.10 million03/11/2024$0.98$0.95-3.21%$1.01$0.91894,109 shs$51.75 million03/08/2024$1.05$0.98-6.53%$1.10$0.96930,311 shs$53.47 million03/07/2024$0.99$1.05+6.05%$1.07$0.99620,987 shs$57.20 million03/06/2024$0.91$0.99+8.80%$1.00$0.89589,399 shs$53.94 million03/05/2024$1.00$0.91-8.98%$0.94$0.831.23 million shs$49.58 million03/04/2024$0.95$1.00+5.24%$1.15$0.972.25 million shs$54.47 millionAI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry03/01/2024$0.85$0.95+11.74%$0.96$0.821.01 million shs$51.76 million02/29/2024$0.89$0.85-4.47%$0.94$0.81843,509 shs$46.32 million02/28/2024$0.95$0.89-5.87%$1.00$0.85774,013 shs$48.49 million02/27/2024$0.80$0.95+18.03%$0.95$0.83794,265 shs$51.51 million02/26/2024$0.91$0.80-11.69%$1.01$0.801.83 million shs$43.64 million02/23/2024$0.80$0.91+13.56%$1.13$0.824.30 million shs$49.42 million02/22/2024$0.68$0.80+18.13%$0.80$0.681.19 million shs$43.52 million02/21/2024$0.64$0.68+5.28%$0.69$0.61381,924 shs$36.84 million02/20/2024$0.63$0.64+2.57%$0.70$0.62607,938 shs$34.99 million02/19/2024$0.63$0.63$0.64$0.56538,500 shs$34.12 million02/16/2024$0.60$0.63+5.19%$0.64$0.56538,370 shs$34.12 million02/15/2024$0.57$0.60+5.34%$0.62$0.57658,830 shs$32.43 million02/14/2024$0.53$0.57+5.98%$0.57$0.53272,680 shs$30.79 million02/13/2024$0.58$0.53-8.54%$0.59$0.52663,656 shs$29.05 million02/12/2024$0.57$0.58+3.04%$0.60$0.56437,246 shs$31.76 million02/09/2024$0.52$0.57+8.79%$0.57$0.52463,250 shs$30.83 million02/08/2024$0.53$0.52-2.29%$0.55$0.52719,411 shs$28.34 million02/07/2024$0.58$0.53-7.73%$0.60$0.53548,273 shs$29 million02/06/2024$0.58$0.58-0.74%$0.60$0.57247,392 shs$31.43 million02/05/2024$0.57$0.58+1.24%$0.59$0.55433,528 shs$31.66 million02/02/2024$0.56$0.57+2.35%$0.59$0.55327,745 shs$31.28 million02/01/2024$0.57$0.56-0.83%$0.58$0.53307,779 shs$30.56 million01/31/2024$0.57$0.57-0.77%$0.60$0.55457,134 shs$30.81 million01/30/2024$0.61$0.57-6.56%$0.61$0.56455,098 shs$31.05 million01/29/2024$0.58$0.61+5.81%$0.62$0.56928,586 shs$33.23 million Related Companies: JanOne Stock Chart ProMIS Neurosciences Stock Chart Ocuphire Pharma Stock Chart Marker Therapeutics Stock Chart Unicycive Therapeutics Stock Chart BriaCell Therapeutics Stock Chart Xilio Therapeutics Stock Chart Bolt Biotherapeutics Stock Chart Fortress Biotech Stock Chart NextCure Stock Chart Receive CARA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CARA) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.